Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

DuPont presents XJ-304 and related compounds as ACAT inhibitors at ACS

Sep. 9, 1998

WHI investigators design novel inhibitors of EGF receptor tyrosine kinase

Sep. 9, 1998

Taisho and Nihon Nohyaku describe development of potential new antipsychotics at ACS meeting

Sep. 9, 1998

Lepirudin more effective than heparin in preventing cardiac events in unstable angina

Sep. 9, 1998

Pfizer selects GH secretagogue as development candidate

Sep. 8, 1998

Lilly's mGlu agonists exert neuroprotective effects in vivo

Sep. 8, 1998

Novel lipid-lowering agent presented by Wayne Hughes Institute at scientific forum

Sep. 8, 1998

Novel actions of statins reported at the 20th Congress of the European Society of Cardiology

Sep. 8, 1998

Efficacy and safety of sublingual apomorphine in treatment of MED

Sep. 7, 1998

Invicorp trial results highlighted at recent congress

Sep. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...